|
21.02.2025 08:30:06
|
EQS-News: Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025
|
EQS-News: ABIVAX
/ Key word(s): Miscellaneous
Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025 Event to Feature Renowned Gastroenterologist Dr. David Rubin, Highlighting the Ulcerative Colitis Treatment Landscape and Abivax’s Pivotal ABTECT Phase 3 Trial PARIS, France – February 21, 2025 – 8:30 AM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing innovative therapies for chronic inflammatory diseases, today announced it will host a Key Opinion Leader (KOL) Investor Webcast on Monday, March 17, 2025, at 9:00 a.m. EDT (2:00 p.m. CET). The webcast will feature Professor David T. Rubin, MD, Chief of the Section of Gastroenterology, Hepatology, and Nutrition and Director of the Inflammatory Bowel Disease Center at The University of Chicago. Dr. Rubin will provide expert insights into the evolving treatment landscape for ulcerative colitis (UC) and discuss expectations for Abivax’s ABTECT Phase 3 trial evaluating obefazimod in adults with moderately to severely active UC. He will also explore obefazimod’s potential to address critical unmet medical needs in UC treatment. Following the presentation, attendees will have the opportunity to participate in a live Q&A session with Dr. Rubin and Abivax’s management team.
ð??? Date: Monday, March 17, 2025 ⏰ Time: 9:00 a.m. EDT | 2:00 p.m. CET ð?? Format: Virtual webcast
To register for the webcast and access further event details, please click on this link https://lifescievents.com/event/abivax-3/.
Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Based in France and the United States, Abivax’s lead drug candidate, obefazimod (ABX464), is in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. More information on the Company is available at www.abivax.com. Follow us on LinkedIn and on X, formerly Twitter, @ABIVAX. Contact: Patrick Malloy
21.02.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
2089465 21.02.2025 CET/CEST
Nachrichten zu Abivax SA
|
21.02.25 |
EQS-News: Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025 (EQS Group) | |
|
28.01.25 |
EQS-News: Abivax Publishes 2025 Financial Calendar (EQS Group) | |
|
09.01.25 |
EQS-News: Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment (EQS Group) | |
|
23.12.24 |
EQS-News: Abivax Announces a Change to the Composition of its Board of Directors (EQS Group) | |
|
19.11.24 |
EQS-News: Abivax Establishes an At-the-Market (ATM) Program on Nasdaq (EQS Group) | |
|
14.11.24 |
EQS-News: Abivax presents third quarter 2024 key financial information (EQS Group) | |
|
13.11.24 |
EQS-News: Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax (EQS Group) | |
|
07.10.24 |
EQS-News: Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation (EQS Group) |
Digital vs Kreditkarten: Wer gewinnt das Zahlungs-Rennen? – Wall Street Live mit Tim Schäfer
In der heutigen Ausgabe von Wall Street Live geht es um Digitale Zahlungssysteme. Warum haben Unternehmen wie Visa, Mastercard und American Express kaum Konkurrenz? Wo liegen die Probleme von PayPal und wird Apple Pay in Zukunft noch mehr im digitalen Zahlungsumfeld mitspielen? Diese und weitere Fragen beantwortet Tim Schäfer in der heutigen Ausgabe von Wall Street Live.
In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer behandeln wir Topaktuelle Themen des Marktgeschehens.
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| Abivax SA | 7.46 | 1.77% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Vor Wahl in Deutschland: SMI geht stärker ins Wochenende -- DAX letztlich etwas leichter -- US-Börsen mit Verlusten -- Asiatische Indizes schliessen stärkerAm Freitag bewegte sich der heimische Aktienmarkt nach oben, während der deutsche Leitindex leicht nachgab. An der Wall Street ging es nach unten. An den wichtigsten asiatischen Börsen ging es vor dem Wochenende unterdessen aufwärts.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |